The Center for American Progress hosted a video conference of Dr. Howard Dean talking about Health Care reform on Tueday. The video is on the web here. On this one hour program, Howard Dean spends a little over 3 minutes responding to allegations that he is a “shill” for BIO, on the issue of biosimilars.
The July 20, 2009 issue of BioCentury has an extensive report on the “Biosimilar fire Drill.” It discusses in detail the lobbying by the Biotechnology Industry Association (BIO, bio.org) to defeat efforts by President Obama, OMB, the FTC, Representative Waxman, Senator Brown, AARP, Public Citizen, PIRG, Consumers Union, KEI, Essential Action, and others, to reform the regulation to biologic medicines, so there is more generic competition. Continue Reading
Note: Only a portion of the speech is reproduced here.
Intervention by Hono’ble Minister of State for External Affairs, Smt. Preneet Kaur
Hon’ble Co-Chairs/Madam Moderator, Distinguished Delegates,
*The author thanks Professor Marc Perlman (Brown University) for his comprehensive notes on the IGC deliberations.
Pope Benedict XVI today issued a statement saying that “On the part of rich countries, there is excessive zeal for protecting knowledge through an unduly rigid assertion of the right to intellectual property, especially in the field of health care.” The criticism came in a section of his most recent encyclical letter dealing with social issues, and specifically focusing on international human development and systemic failures of bodies large and small to solve development problems.
Today nine NGOs sent a letter the WHO Expert Working Group on R&D Financing. The letter focuses on issues about transparency, conflicts of interest, and EWG outcomes. The whole EWG seems to be going very badly right now, in part because of the US government and much of Northern Europe is working hand and glove with the pharmaceutical industry, and partly because the Gates Foundation is protecting big pharma and seems to have an ideological attachment to strong IPR.
The US Department of State “2009 Investment Climate Statement for Switzerland” provides an interesting and often unexpected portrait of the intellectual property landscape for a country that is often a hard-liner in global IPR negotiations. Continue Reading
Today the executive board of the Pan American Health Organization (PAHO) is considering a proposal to have more transparency of the economics of the pharmaceutical industry. (I have separately blogged about this on the Huffpo). Specifically, an amendment offered to a PAHO EB resolution on research, proposed the following:
On Friday, May 29, the 18th Session of the WIPO Standing Committee on Copyright and Related Rights (SCCR) agreed to consider a proposal submitted by the governments of Brazil, Ecuador and Paraguay Relating to Limitations and Exceptions on a Treaty for Reading Disabled Persons at its next meeting in November 2009 (19th Session). KEI has collated views on the outcome of the 18th SCCR from the following countries and NGOs.
Views on the outcome of WIPO SCCR 18: Brazil, Ecuador and Paraguay Treaty for Reading Disabled Persons
Our impressions about this appointment are positive, but we would like to hear from others. IBM has been very smart on IPR issues lately, recognizing that knowledge is often more valuable when shared. Coming from a successful technology firm, he will have both credibility and insight into innovation policy. He brings more balance to the job than anyone we can remember. Below are some interesting quotes from various articles.